新生兒醫學
高膽紅素血症治療 (Hyperbilirubinemia)
光照治療
Randomised controlled trial of single phototherapy with reflecting curtains versus double phototherapy in term newborns with hyperbilirubinaemia. （開啟新視窗）
出處: J Paediatr Child Health 2013;49(5):375-9.
檢索: PubMed 23573836
DOI碼: 10.1111/jpc.12192
Effect of white plastic cover around the phototherapy unit on hyperbilirubinemia in full term neonates. （開啟新視窗）
出處: Iran J Pediatr 2013;23(2):143-8.
檢索: PubMed 23724173
Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. （開啟新視窗）
出處: Pediatrics 2011;128(4):e1046-52.
檢索: PubMed 21949150
DOI碼: 10.1542/peds.2011-1494
High-intensity phototherapy for the treatment of severe nonhaemolytic neonatal hyperbilirubinemia. （開啟新視窗）
出處: Acta Paediatr 2011;100(4):620-3.
檢索: PubMed 21251060
DOI碼: 10.1111/j.1651-2227.2011.02170.x
Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. （開啟新視窗）
出處: Arch Dis Child Fetal Neonatal Ed 2006;91(6):F439-42.
檢索: PubMed 16877479
DOI碼: 10.1136/adc.2006.095687
Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. （開啟新視窗）
出處: Cochrane Database Syst Rev 2012;(12):CD009017.
檢索: PubMed 23235669
DOI碼: 10.1002/14651858.CD009017.pub2
Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. （開啟新視窗）
出處: Cochrane Database Syst Rev 2011;(12):CD007969.
檢索: PubMed 22161417
DOI碼: 10.1002/14651858.CD007969.pub2
Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. （開啟新視窗）
出處: J Perinatol 2013;33(2):126-33.
檢索: PubMed 22499082
DOI碼: 10.1038/jp.2012.39
Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. （開啟新視窗）
出處: Cochrane Database Syst Rev 2012;(1):CD007966.
檢索: PubMed 22258977
DOI碼: 10.1002/14651858.CD007966.pub2
The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice. （開啟新視窗）
出處: Indian J Med Sci 2009;63(5):174-9.
檢索: PubMed 19584487
DOI碼: 10.4103/0019-5359.53162
A randomized trial of phototherapy with filtered sunlight in African neonates. （開啟新視窗）
出處: N Engl J Med 2015;373(12):1115-24.
檢索: PubMed 26376136
DOI碼: 10.1056/NEJMoa1501074
Dose-response relationship of phototherapy for hyperbilirubinemia. （開啟新視窗）
出處: Pediatrics 2012;130(2):e352-7.
檢索: PubMed 22802603
DOI碼: 10.1542/peds.2011-3235
靜脈注射免疫球蛋白（IVIG）
High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. （開啟新視窗）
出處: Acta Paediatr 1999;88(2):216-9.
檢索: PubMed 10102158
High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. （開啟新視窗）
出處: J Int Med Res 1995;23(4):264-71.
檢索: PubMed 7589769
DOI碼: 10.1177/030006059502300406
Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. （開啟新視窗）
出處: Arch Dis Child Fetal Neonatal Ed 2003;88(1):F6-10.
檢索: PubMed 12496219
Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy. （開啟新視窗）
出處: Biol Neonate 1996;70(2):69-74.
檢索: PubMed 8864425
Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and ABO incompatibility. （開啟新視窗）
出處: Acta Paediatr 2008;97(10):1362-5.
檢索: PubMed 18616629
DOI碼: 10.1111/j.1651-2227.2008.00915.x
Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. （開啟新視窗）
出處: J Matern Fetal Neonatal Med 2004;16(3):163-6.
檢索: PubMed 15590442
DOI碼: 10.1080/14767050400009873
錫中卟啉（SnMP）
Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia. （開啟新視窗）
出處: J Perinatol 2016;36(7):533-9.
檢索: PubMed 26938918
DOI碼: 10.1038/jp.2016.22
Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion. （開啟新視窗）
出處: Pediatrics 2001;108(6):1374-7.
檢索: PubMed 11731664
A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. （開啟新視窗）
出處: Pediatrics 2004;113(1 Pt 1):119-23.
檢索: PubMed 14702459
Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. （開啟新視窗）
出處: J Perinatol 2003;23(6):507-8.
檢索: PubMed 13679941
DOI碼: 10.1038/sj.jp.7210943
其他製劑
Phenobarbitone for prevention and treatment of unconjugated hyperbilirubinemia in preterm neonates: a systematic review and meta-analysis. （開啟新視窗）
出處: Indian Pediatr 2010;47(5):401-7.
檢索: PubMed 19736369
Single dose of 50 mg/kg clofibrate in jaundice of healthy term neonates: randomised clinical trial of efficacy and safety. （開啟新視窗）
出處: Indian J Pediatr 2012;79(2):194-7.
檢索: PubMed 21785863
DOI碼: 10.1007/s12098-011-0531-9
Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. （開啟新視窗）
出處: J Pediatr Gastroenterol Nutr 2016;62(1):97-100.
檢索: PubMed 26020375
DOI碼: 10.1097/MPG.0000000000000874
Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. （開啟新視窗）
出處: Pediatrics 2009;124(4):1193-8.
檢索: PubMed 19786452
DOI碼: 10.1542/peds.2009-0329
A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. （開啟新視窗）
出處: J Pediatr 2005;147(6):781-5.
檢索: PubMed 16356431
DOI碼: 10.1016/j.jpeds.2005.07.026
Treatment of clofibrate in jaundiced low birth weight neonates. [English, Turkish abstract] （開啟新視窗）
出處: UHOD-Uluslar Hematol Onkol De (Int J Hematol Oncol) 2009;19(2):100-5.
檢索: EMBASE 2009472903
Clofibrate for unconjugated hyperbilirubinemia in neonates: a systematic review. （開啟新視窗）
出處: Indian Pediatr 2012;49(1):35-41.
檢索: PubMed 22318100
Interscapular site for transcutaneous bilirubin measurement in preterm infants: a better and safer screening site. （開啟新視窗）
出處: J Perinatol 2014;34(3):209-12.
檢索: PubMed 24406742
DOI碼: 10.1038/jp.2013.167
Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). （開啟新視窗）
出處: Southeast Asian J Trop Med Public Health 2008;39(3):557-61.
檢索: PubMed 18564698